BioRem (BRM) Stock Price, News & Analysis

Company Overview

BioRem Inc., a clean technology engineering company, designs, manufactures, distributes, and sells air pollution control systems that are used to eliminate odors, volatile organic compounds (VOCs), and hazardous air pollutants (HAPs). It offers biofilters for the removal of odors, H2S, VOCs, and HAPs; and biotrickling filters for applications of high levels of H2S or other water-soluble VOCs. The company also provides multi-stage systems to remove odors from various municipal/urban wastewater treatment processes; biogas desulfurization systems; dry scrubber adsorption systems; and cannabis odor control systems. In addition, it offers biological processes and testing services; media sampling and analysis; system review and inspections; and media replacements and spare parts. The company operates in Canada, the United States, China, and internationally. BioRem Inc. was founded in 1990 and is headquartered in Puslinch, Canada.

Key Stats

• Today's Range: C$1.67 to C$1.82
• 50-Day Range: C$1.76 to C$2.61
• 52-Week Range: C$1.67 to C$3.45
• Volume: 152,196 shs
• Average Volume: 46,413 shs
• Market Capitalization: C$29.19 million
• P/E Ratio: 5.50
• Dividend Yield: 6.47%
• Price Target: N/A
• Consensus Rating: N/A

BRM Stock Analysis - Frequently Asked Questions

How have BRM shares performed this year?

BioRem's stock was trading at C$3.05 at the beginning of 2025. Since then, BRM stock has decreased by 41.6% and is now trading at C$1.78.
View the best growth stocks for 2025 here.

How were BioRem's earnings last quarter?

BioRem Inc. (CVE:BRM) announced its quarterly earnings data on Wednesday, November, 6th. The company reported $0.12 earnings per share for the quarter. BioRem had a net margin of 12.91% and a trailing twelve-month return on equity of 65.14%.

How do I buy shares of BioRem?

Shares of BRM stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What other stocks do shareholders of BioRem own?

Based on aggregate information from My MarketBeat watchlists, some other companies that BioRem investors own include TVA Group (TVA.B), Questor Technology (QST), AutoZone (AZO), Cadence Design Systems (CDNS), FormFactor (FORM), Intel (INTC) and K92 Mining Inc. (KNT.V) (KNT).

Company Calendar

• Last Earnings: 11/06/2024
• Today: 5/12/2025

Industry, Sector and Symbol

• Stock Exchange: CVE
• Sector: Industrials
• Industry: Pollution & Treatment Controls
• Sub-Industry: Pharmaceutical Products
• Current Symbol: CVE:BRM
• CIK: N/A
• Web: www.biorem.biz
• Phone: +1-519-7679100
• Fax: N/A
• Employees: 34,300
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): C$0.32
• Trailing P/E Ratio: 5.50
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: C$5.40 million
• Net Margins: 12.91%
• Pretax Margin: N/A
• Return on Equity: 65.14%
• Return on Assets: 14.61%

Debt

• Debt-to-Equity Ratio: 37.47
• Current Ratio: 1.91
• Quick Ratio: 1.08

Sales & Book Value

• Annual Sales: C$41.84 million
• Price / Sales: 0.70
• Cash Flow: C$0.48 per share
• Price / Cash Flow: 3.70
• Book Value: C$0.63 per share
• Price / Book: 2.83

Miscellaneous

• Outstanding Shares: 16,397,626
• Free Float: N/A
• Market Cap: C$29.19 million
• Optionable: Not Optionable
• Beta: 0.85